Florian Rüker
Corporate Officer/Principal bei University of Vienna
Aktive Positionen von Florian Rüker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Vienna | Corporate Officer/Principal | 12.01.2010 | - |
| University of Natural Resources & Life Sciences | Corporate Officer/Principal | - | - |
Karriereverlauf von Florian Rüker
Ehemalige bekannte Positionen von Florian Rüker
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2006 | - |
| Gründer | 01.01.2006 | - | |
| New Century Pharmaceuticals, Inc. | Corporate Officer/Principal | - | - |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Direktor/Vorstandsmitglied | 12.06.2006 | - |
| Gründer | 12.06.2006 | - |
Ausbildung von Florian Rüker
| University of Vienna | Doctorate Degree |
Statistik
International
| Österreich | 5 |
| Vereinigte Staaten | 2 |
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Founder | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
| New Century Pharmaceuticals, Inc. | |
F-star Alpha Ltd.
F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology F-Star Biotechnology Ltd. is a biopharmaceutical company. It discovers, develops, and manufactures bispecific antibody products. The company is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Florian Rüker
- Erfahrung